Summit Therapeutics
$5.229876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.22
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.08 (-1.51%) Today
$0.00 (0.00%) As of 10:14 PM UTC after-hours
Why Robinhood?
You can buy or sell SMMT and other stocks, options, and ETFs commission-free!
About SMMT
Summit Therapeutics, Inc. develops biopharmaceutical products. The company was founded on July 17, 2020 and is headquartered in Wilmington, DE. The listed name for SMMT is Summit Therapeutics Inc. Common Stock.
CEO
Robert William Duggan
Employees
70
Headquarters
Cambridge, Massachusetts
Founded
—
Market Cap
427.78M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
197.58K
High Today
$5.40
Low Today
$5.05
Open Price
$5.31
Volume
207.54K
52 Week High
$6.14
52 Week Low
$1.18
Collections
SMMT Earnings
-$0.40
-$0.27
-$0.13
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Apr 29, Pre-Market